NASDAQ:CCAP Crescent Capital BDC (CCAP) Stock Price, News & Analysis $9.27 -0.03 (-0.32%) Closing price 10/30/2026 04:00 PM EasternExtended Trading$9.28 +0.02 (+0.16%) As of 10/30/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Crescent Capital BDC Stock (NASDAQ:CCAP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Crescent Capital BDC alerts:Sign Up Key Stats Today's Range$9.10▼$9.3250-Day Range$8.50▼$10.7552-Week Range$8.40▼$15.18Volume233,456 shsAverage Volume223,698 shsMarket Capitalization$341.60 millionP/E RatioN/ADividend Yield14.67%Price Target$12.25Consensus RatingHold Company Overview Crescent Capital BDC, Inc. is a business development company that provides financing to middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by investing in privately negotiated debt and equity securities. Its investment portfolio is focused primarily on senior secured loans, including first-lien and second-lien loans, as well as other debt investments and selected equity interests. Crescent Capital BDC generally works with established companies across a range of industries, providing capital for acquisitions, recapitalizations, refinancing, growth initiatives and other corporate purposes. The company is externally managed by Crescent Cap Advisors LLC, an affiliate of Crescent Capital Group LP, an investment firm specializing in credit and alternative investments. Crescent Capital BDC primarily serves middle-market businesses in the United States and operates under the regulatory framework governing business development companies.AI Generated. May Contain Errors. Read More Crescent Capital BDC Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks89th Percentile Overall ScoreCCAP MarketRank™: 4.4717620973 of 5 starsCrescent Capital BDC scored higher than 89% of companies evaluated by MarketBeat, and ranked 194th out of 859 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingCrescent Capital BDC has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no strong buy ratings, 1 buy rating, 6 hold ratings, and no sell ratings.Upside PotentialCrescent Capital BDC has a consensus price target of $12.25, representing about 32.1% upside from its current price of $9.27.Amount of Analyst CoverageCrescent Capital BDC has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Crescent Capital BDC's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-4.70% Earnings GrowthEarnings for Crescent Capital BDC are expected to decrease by -4.70% in the coming year, from $1.49 to $1.42 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Crescent Capital BDC is -103.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Crescent Capital BDC is -103.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCrescent Capital BDC has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Crescent Capital BDC's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.22% of the float of Crescent Capital BDC has been sold short.Short Interest Ratio / Days to CoverCrescent Capital BDC has a short interest ratio ("days to cover") of 2.97, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Crescent Capital BDC has recently decreased by 3.92%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipCrescent Capital BDC is a leading dividend payer. It pays a dividend yield of 14.67%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthCrescent Capital BDC has only been increasing its dividend for 1 years.Dividend SustainabilityBased on EPS estimates, Crescent Capital BDC will have a dividend payout ratio of 95.77% in the coming year. This indicates that Crescent Capital BDC may not be able to sustain their current dividend.Read more about Crescent Capital BDC's dividend. News and Social Media3.3 / 5News Sentiment1.29 News SentimentCrescent Capital BDC has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Crescent Capital BDC this week, compared to 3 articles on an average week.Search InterestOnly 4 people have searched for CCAP on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Crescent Capital BDC to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.8 / 5Insider TradingSelling Shares Cluster Insider Buying2 insiders have purchased shares of Crescent Capital BDC in the last three months. Multiple insiders buying is a strong bullish signal.Insider Buying vs. Insider SellingIn the past three months, Crescent Capital BDC insiders have sold 9,462.11% more of their company's stock than they have bought. Specifically, they have bought $49,045.00 in company stock and sold $4,689,738.00 in company stock.Percentage Held by Insiders1.23% of the stock of Crescent Capital BDC is held by insiders.Percentage Held by Institutions49.46% of the stock of Crescent Capital BDC is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Crescent Capital BDC's insider trading history. Receive CCAP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Crescent Capital BDC and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CCAP Stock News HeadlinesCrescent Capital BDC Announces Third Quarter 2026 Earnings Release and Conference Call DateOctober 30 at 4:31 PM | quiverquant.comQCrescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Third Quarter Ended September 30, 2026 Financial ResultsOctober 30 at 4:20 PM | globenewswire.comFederal Reserve’s Disturbing Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.November 1 at 1:00 AM | Weiss Ratings (Ad)5 Overlooked Dividend Stocks Paying Up to 17.5%. Here's the CatchOctober 21, 2026 | 247wallst.comCrescent Capital: Coverage Restoration, Fee Reduction And Rate Hikes Are CatalystsSeptember 23, 2026 | seekingalpha.com5 Big Dividend Yields With Ex-Dividend Dates Coming Up FastSeptember 18, 2026 | 247wallst.com6 Dividend Stocks With Huge Yields and Even Bigger Warning SignsSeptember 16, 2026 | 247wallst.comB of A Securities Downgrades Crescent Capital BDC to Neutral from BuySeptember 10, 2026 | msn.comSee More Headlines CCAP Stock Analysis - Frequently Asked Questions How have CCAP shares performed this year? Crescent Capital BDC's stock was trading at $14.05 at the beginning of the year. Since then, CCAP shares have decreased by 34.0% and is now trading at $9.27. How were Crescent Capital BDC's earnings last quarter? Crescent Capital BDC, Inc. (NASDAQ:CCAP) released its quarterly earnings data on Monday, August, 10th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by $0.01. The business had revenue of $5.12 million for the quarter, compared to the consensus estimate of $37.12 million. Crescent Capital BDC had a negative net margin of 2.02% and a positive trailing twelve-month return on equity of 9.02%. Read the conference call transcript. Who are Crescent Capital BDC's major shareholders? Crescent Capital BDC's top institutional shareholders include Beach Point Capital Management LP (1.40%), Adams Asset Advisors LLC (0.32%), Oppenheimer & Co. Inc. (0.18%) and Confluence Investment Management LLC (0.11%). Insiders that own company stock include & Guaranty Life Insur Fidelity, California Emplo Ufcw-Northern, Jason Breaux, Gerhard Lombard, Henry Chung, Raymond Barrios and Kirill Bouek. View institutional ownership trends. How do I buy shares of Crescent Capital BDC? Shares of CCAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Crescent Capital BDC own? Based on aggregate information from My MarketBeat watchlists, some other companies that Crescent Capital BDC investors own include Rithm Capital (RITM), Energy Transfer (ET), Enterprise Products Partners (EPD), Ares Capital (ARCC), AGNC Investment (AGNC), Capital Southwest (CSWC) and AT&T (T). Company Calendar Last Earnings8/10/2026Record date for 10/15 Dividend9/30/2026Ex-Dividend for 10/15 Dividend9/30/2026Dividend Payable10/15/2026Today11/01/2026Next Earnings (Estimated)11/11/2026Record date for 12/15 Dividend11/30/2026Ex-Dividend for 12/15 Dividend11/30/2026Dividend Payable12/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (11m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CCAP's financial health is in the Red zone, according to TradeSmith. CCAP has been in this zone for over 11 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Capital Markets Sub-IndustryAsset Management & Custody Banks Current SymbolNASDAQ:CCAP CIK1633336 Webwww.crescentbdc.com Phone310-235-5900FaxN/AEmployees250Year Founded2019Price Target and Rating Average Price Target for Crescent Capital BDC$12.25 High Price Target$16.00 Low Price Target$10.00 Potential Upside/Downside+32.1%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($0.09) Trailing P/E RatioN/A Forward P/E Ratio6.22 P/E GrowthN/ANet Income$34.51 million Net Margins-2.02% Pretax Margin40.82% Return on Equity9.02% Return on Assets3.82% Debt Debt-to-Equity Ratio1.41 Current Ratio1.30 Quick Ratio1.30 Sales & Book Value Annual Sales$167.29 million Price / Sales2.04 Cash Flow$1.72 per share Price / Cash Flow5.40 Book Value$19.09 per share Price / Book0.49Miscellaneous Outstanding Shares36,850,000Free Float36,393,000Market Cap$341.60 million OptionableOptionable Beta0.57 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NASDAQ:CCAP) was last updated on 10/30/2026 by MarketBeat.com Staff. From Our PartnersFinancial Legend: “Big trouble ahead …”Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution ri...Weiss Ratings | SponsoredWhat Elon Musk's Cybercab Reveal Could Mean for InvestorsJeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredDoes your nest egg have an expiration date?A $250,000 nest egg growing at 5% a year and paying out $2,500 a month runs dry in just over a decade. Start w...Investors Alley | SponsoredThe Claude AI company doubled in value... you missed itIn May, Anthropic raised money at a $965 billion valuation. Now, ahead of its IPO, investors are reportedly di...Crypto 101 Media | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescent Capital BDC, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescent Capital BDC With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
